Systemic oxidative stress and endothelial dysfunction is associated with an attenuated acute vascular response to inhaled prostanoid in pulmonary artery hypertension patients

Journal of Cardiac Failure

Volumn 17, Issue 12, 2011, Pages 1012-1017

  Gabrielli, Luigi A ^a   Castro, Pablo F ^a   Godoy, Ivan ^a   Mellado, Rosemarie ^a   Bourge, Robert C ^b   Alcaino, Hernan ^c   Chiong, Mario ^d   Greig, Douglas ^a   Verdejo, Hugo E ^a,d   Navarro, Mario ^d   Lopez, Rafael ^d   Toro, Barbra ^d   Quiroga, Clara ^d   Díaz Araya, Guillermo ^d   Lavandero, Sergio ^d,e,f   Garcia, Lorena ^d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSIDAD DE VALPARAÍSO   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

^e UNIVERSITY OF CHILE   (Chile)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

endothelial function; endothelial superoxide dismutase; oxidative stress; Pulmonary hypertension

Indexed keywords

ILOPROST; MALONALDEHYDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FEMALE; HEART OUTPUT; HUMAN; LUNG BLOOD VESSEL; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TRANSTHORACIC ECHOCARDIOGRAPHY; VASODILATATION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADULT; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PROSTAGLANDINS; PULMONARY ARTERY; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

EID: 84855979023     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.08.008     Document Type: Article

References (26)

1. G.E. D'Alonzo, R.J. Barst, S.M. Ayres, E.H. Bergofsky, B.H. Brundage, and K.M. Detre Survival in patients with primary pulmonary hypertension: results from a national prospective registry Ann Intern Med 115 1991 343 349
2. A.T. Dinh-Xuan Endothelial modulation of pulmonary vascular tone Eur Respir J 5 1992 757 762
3. B. Wolff, S. Lodziewski, T. Bollmann, C.F. Opitz, and R. Ewert Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost Am Heart J 153 2007 1088e1-7
4. R. Bowers, C. Cool, R.C. Murphy, R.M. Tuder, S.C. Flores, and M.W. Hopken Oxidative stress in severe pulmonary hypertension Am J Respir Crit Care Med 169 2004 764 769 (Pubitemid 38338929)
5. P. Crosswhite, and Z. Sun Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension J Hypertens 28 2010 201 212
6. E. Cadenas, and H. Sies Oxidative stress: excited oxygen species and enzyme activity Adv Enzyme Regul 23 1985 217 237
7. S. Spiekerman, K. Schenk, and M.M. Hoeper Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension Eur Respir J 34 2009 276 283
8. N.L. Irodova, V.Z. Lankin, G.K. Konovalova, A.G. Kochetov, and E. ChazovaI Oxidative stress in patients with primary pulmonary hypertension Bull Exp Biol Med 133 2002 580 582 (Pubitemid 35345240)
9. P.F. Castro, G. Díaz-Araya, D. Nettle, R. Corbalán, O. Pérez, and C. Nazzal Effects of early decrease in oxidative stress after medical therapy in patients with class IV congestive heart failure Am J Cardiol 89 2002 236 239 (Pubitemid 34132920)
10. P.F. Castro, D. Greig, O. Pérez, F. Moraga, M. Chiong, and G. Díaz-Araya Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 92 2003 215 218 (Pubitemid 36835976)
11. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, and C.P. Denton Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
12. N. Galié, M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, and J.A. Barbera Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 30 2009 2493 2537
13. Z.C. Jing, X. Jiang, Z.Y. Han, X.Q. Xu, Y. Wang, and Y. Wu Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension Eur Respir J 33 2009 1354 1360
14. H. Olschewski, G. Simonneau, N. Gali, T. Higenbottam, R. Naeije, and L.J. Rubin Inhaled Iloprost for severe pulmonary hypertension N Engl J Med 347 2002 332 339
15. D.S. Celermajer Testing endothelial function using ultrasound J Cardiovasc Pharmacol 32 1998 S29 S32
16. N. Selimovic, B. Rundqvist, C.H. Bergh, B. Andersson, S. Petersson, and L. Johansson Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension J Heart Lung Transplant 26 2007 927 934 (Pubitemid 47369201)
17. P.F. Castro, R. Miranda, H.E. Verdejo, D. Greig, L.A. Gabrielli, and H. Alcaino Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity J Heart Lung Transplant 27 2008 435 441 (Pubitemid 351418248)
18. N. Prajda, and G. Weber Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas FEBS Lett 59 1975 245 249
19. U. Landmesser, S. Spiekermann, S. Dikalov, H. Tatge, R. Wilke, and C. Kohler Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase Circulation 106 2002 3073 3078 (Pubitemid 35440291)
20. J.A. Madden, M.S. Vadula, and V.P. Kurup Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells Am J Physiol 263 1992 L384 L393
21. N.W. Morrell, S. Adnot, S.L. Archer, J. Dupuis, P.L. Jones, and M.R. MacLean Cellular and molecular basis of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S20 S31
22. H.W. Farber, and J. Loscalzo Pulmonary arterial hypertension N Engl J Med 351 2004 1655 1665
23. P. Yildiz Molecular mechanisms of pulmonary hypertension Clin Chim Acta 403 2009 9 16
24. W. Jacobs, and A. Vonk-Noordegraf Epoprostenol in pulmonary arterial hypertension Expert Opin Drug Metab Toxicol 5 2009 83 90
25. K. Shinmura, K. Tamaki, T. Sato, H. Ishida, and R. Bolli Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor Am J Physiol 288 2005 H2093 H2210
26. G. Habib, and A. Torbicki The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension Eur Respir Rev 19 2010 288 299